Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global HER2 Antibody, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 HER2 Antibody Product Introduction
  • 1.2 Market Segments
  • 1.3 Key HER2 Antibody Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global HER2 Antibody Market Size Growth Rate by Type
    • 1.4.2 Trastuzumab
    • 1.4.3 Lapatinib
    • 1.4.4 Ado-trastuzumab Emtansine
    • 1.4.5 Pertuzumab
    • 1.4.6 Everolimus
  • 1.5 Market by Application
    • 1.5.1 Global HER2 Antibody Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Center
  • 1.6 Coronavirus Disease 2019 (Covid-19): HER2 Antibody Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the HER2 Antibody Industry
      • 1.6.1.1 HER2 Antibody Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and HER2 Antibody Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for HER2 Antibody Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global HER2 Antibody Market Size Estimates and Forecasts
    • 2.1.1 Global HER2 Antibody Revenue 2015-2026
    • 2.1.2 Global HER2 Antibody Sales 2015-2026
  • 2.2 HER2 Antibody Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global HER2 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global HER2 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global HER2 Antibody Competitor Landscape by Players

  • 3.1 HER2 Antibody Sales by Manufacturers
    • 3.1.1 HER2 Antibody Sales by Manufacturers (2015-2020)
    • 3.1.2 HER2 Antibody Sales Market Share by Manufacturers (2015-2020)
  • 3.2 HER2 Antibody Revenue by Manufacturers
    • 3.2.1 HER2 Antibody Revenue by Manufacturers (2015-2020)
    • 3.2.2 HER2 Antibody Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2019
    • 3.2.5 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 HER2 Antibody Price by Manufacturers
  • 3.4 HER2 Antibody Manufacturing Base Distribution, Product Types
    • 3.4.1 HER2 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers HER2 Antibody Product Type
    • 3.4.3 Date of International Manufacturers Enter into HER2 Antibody Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global HER2 Antibody Market Size by Type (2015-2020)
    • 4.1.1 Global HER2 Antibody Sales by Type (2015-2020)
    • 4.1.2 Global HER2 Antibody Revenue by Type (2015-2020)
    • 4.1.3 HER2 Antibody Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global HER2 Antibody Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global HER2 Antibody Sales Forecast by Type (2021-2026)
    • 4.2.2 Global HER2 Antibody Revenue Forecast by Type (2021-2026)
    • 4.2.3 HER2 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global HER2 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global HER2 Antibody Market Size by Application (2015-2020)
    • 5.1.1 Global HER2 Antibody Sales by Application (2015-2020)
    • 5.1.2 Global HER2 Antibody Revenue by Application (2015-2020)
    • 5.1.3 HER2 Antibody Price by Application (2015-2020)
  • 5.2 HER2 Antibody Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global HER2 Antibody Sales Forecast by Application (2021-2026)
    • 5.2.2 Global HER2 Antibody Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global HER2 Antibody Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America HER2 Antibody by Country
    • 6.1.1 North America HER2 Antibody Sales by Country
    • 6.1.2 North America HER2 Antibody Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America HER2 Antibody Market Facts & Figures by Type
  • 6.3 North America HER2 Antibody Market Facts & Figures by Application

7 Europe

  • 7.1 Europe HER2 Antibody by Country
    • 7.1.1 Europe HER2 Antibody Sales by Country
    • 7.1.2 Europe HER2 Antibody Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe HER2 Antibody Market Facts & Figures by Type
  • 7.3 Europe HER2 Antibody Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific HER2 Antibody by Region
    • 8.1.1 Asia Pacific HER2 Antibody Sales by Region
    • 8.1.2 Asia Pacific HER2 Antibody Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific HER2 Antibody Market Facts & Figures by Type
  • 8.3 Asia Pacific HER2 Antibody Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America HER2 Antibody by Country
    • 9.1.1 Latin America HER2 Antibody Sales by Country
    • 9.1.2 Latin America HER2 Antibody Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America HER2 Antibody Market Facts & Figures by Type
  • 9.3 Central & South America HER2 Antibody Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa HER2 Antibody by Country
    • 10.1.1 Middle East and Africa HER2 Antibody Sales by Country
    • 10.1.2 Middle East and Africa HER2 Antibody Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa HER2 Antibody Market Facts & Figures by Type
  • 10.3 Middle East and Africa HER2 Antibody Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Genentech Inc
    • 11.1.1 Genentech Inc Corporation Information
    • 11.1.2 Genentech Inc Description, Business Overview and Total Revenue
    • 11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Genentech Inc HER2 Antibody Products Offered
    • 11.1.5 Genentech Inc Recent Development
  • 11.2 Novartis AG
    • 11.2.1 Novartis AG Corporation Information
    • 11.2.2 Novartis AG Description, Business Overview and Total Revenue
    • 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis AG HER2 Antibody Products Offered
    • 11.2.5 Novartis AG Recent Development
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description, Business Overview and Total Revenue
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer HER2 Antibody Products Offered
    • 11.3.5 Pfizer Recent Development
  • 11.4 Abnova Corporation
    • 11.4.1 Abnova Corporation Corporation Information
    • 11.4.2 Abnova Corporation Description, Business Overview and Total Revenue
    • 11.4.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Abnova Corporation HER2 Antibody Products Offered
    • 11.4.5 Abnova Corporation Recent Development
  • 11.5 InvivoGen
    • 11.5.1 InvivoGen Corporation Information
    • 11.5.2 InvivoGen Description, Business Overview and Total Revenue
    • 11.5.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 InvivoGen HER2 Antibody Products Offered
    • 11.5.5 InvivoGen Recent Development
  • 11.6 Celltrion
    • 11.6.1 Celltrion Corporation Information
    • 11.6.2 Celltrion Description, Business Overview and Total Revenue
    • 11.6.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Celltrion HER2 Antibody Products Offered
    • 11.6.5 Celltrion Recent Development
  • 11.7 Biocon Limited
    • 11.7.1 Biocon Limited Corporation Information
    • 11.7.2 Biocon Limited Description, Business Overview and Total Revenue
    • 11.7.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Biocon Limited HER2 Antibody Products Offered
    • 11.7.5 Biocon Limited Recent Development
  • 11.8 Bio-Techne
    • 11.8.1 Bio-Techne Corporation Information
    • 11.8.2 Bio-Techne Description, Business Overview and Total Revenue
    • 11.8.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Bio-Techne HER2 Antibody Products Offered
    • 11.8.5 Bio-Techne Recent Development
  • 11.1 Genentech Inc
    • 11.1.1 Genentech Inc Corporation Information
    • 11.1.2 Genentech Inc Description, Business Overview and Total Revenue
    • 11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Genentech Inc HER2 Antibody Products Offered
    • 11.1.5 Genentech Inc Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 HER2 Antibody Market Estimates and Projections by Region
    • 12.1.1 Global HER2 Antibody Sales Forecast by Regions 2021-2026
    • 12.1.2 Global HER2 Antibody Revenue Forecast by Regions 2021-2026
  • 12.2 North America HER2 Antibody Market Size Forecast (2021-2026)
    • 12.2.1 North America: HER2 Antibody Sales Forecast (2021-2026)
    • 12.2.2 North America: HER2 Antibody Revenue Forecast (2021-2026)
    • 12.2.3 North America: HER2 Antibody Market Size Forecast by Country (2021-2026)
  • 12.3 Europe HER2 Antibody Market Size Forecast (2021-2026)
    • 12.3.1 Europe: HER2 Antibody Sales Forecast (2021-2026)
    • 12.3.2 Europe: HER2 Antibody Revenue Forecast (2021-2026)
    • 12.3.3 Europe: HER2 Antibody Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific HER2 Antibody Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: HER2 Antibody Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: HER2 Antibody Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: HER2 Antibody Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America HER2 Antibody Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: HER2 Antibody Sales Forecast (2021-2026)
    • 12.5.2 Latin America: HER2 Antibody Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: HER2 Antibody Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa HER2 Antibody Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: HER2 Antibody Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: HER2 Antibody Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: HER2 Antibody Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key HER2 Antibody Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 HER2 Antibody Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    HER2 Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HER2 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the HER2 Antibody market is segmented into
    Trastuzumab
    Lapatinib
    Ado-trastuzumab Emtansine
    Pertuzumab
    Everolimus

    Segment by Application, the HER2 Antibody market is segmented into
    Hospital
    Medical Center

    Regional and Country-level Analysis
    The HER2 Antibody market is analysed and market size information is provided by regions (countries).
    The key regions covered in the HER2 Antibody market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and HER2 Antibody Market Share Analysis
    HER2 Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HER2 Antibody business, the date to enter into the HER2 Antibody market, HER2 Antibody product introduction, recent developments, etc.
    The major vendors covered:
    Genentech Inc
    Novartis AG
    Pfizer
    Abnova Corporation
    InvivoGen
    Celltrion
    Biocon Limited
    Bio-Techne

    Buy now